EUCTR2005-001618-42-IT进行中（未招募）不适用
A Phase 2, Open-label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancer
AMGE0 个研究点目标入组 88 人开始时间: 2005年10月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancerocally advanced or metastatic thyroid cancerEUCTR2005-001618-42-HUAmgen Inc.160
进行中（未招募）
不适用
A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancerocally advanced or metastatic thyroid cancerEUCTR2005-001618-42-BEAmgen Inc.160
进行中（未招募）
不适用
A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancerocally advanced or metastatic thyroid cancerMedDRA version: 8.1Level: LLTClassification code 10055107Term: Thyroid cancer metastaticEUCTR2005-001618-42-SEAmgen Inc.160
进行中（未招募）
不适用
A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancerocally advanced or metastatic thyroid cancerMedDRA version: 8.1Level: LLTClassification code 10055107Term: Thyroid cancer metastaticEUCTR2005-001618-42-ATAmgen Inc.160
进行中（未招募）
不适用
A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancerocally advanced or metastatic thyroid cancerMedDRA version: 8.1Level: LLTClassification code 10055107Term: Thyroid cancer metastaticEUCTR2005-001618-42-DKAmgen Inc.160